Stratasys Develops Coalition to Produce COVID-19 Face Shields
Over 150 organizations responding to pandemic. Requests from hospitals and other organizations exceed 350,000 shields; first hospital shipment received on Mar. 25
Over 150 organizations responding to pandemic. Requests from hospitals and other organizations exceed 350,000 shields; first hospital shipment received on Mar. 25
Stratasys and Origin have signed an agreement in which Stratasys will market and promote Origin 3D-printed nasopharyngeal (NP) swabs to healthcare providers and other testing centers in the U.S.
When the press reports on additive manufacturing, the line between what’s possible now and what may be coming in the future is sometimes blurry. People love to read about breakthroughs taking place in university labs and company R&D centers—the reports of which always include Star Trek-like possibilities of what those breakthroughs may portend.
The North American medical startup Marvel Medtech purchased an XJet Carmel 1400C 3D printer in the summer of 2019 to build key components in tools for fighting breast cancer.
While 3D printing for dental applications is generally recognized as a mature technology, material innovation continues apace. An emerging trend has been for machine and material suppliers to augment their portfolios by working with or acquiring outside partners.
The medical industry is constantly seeking out new, cutting-edge technologies to disrupt standard practices for the better.
Speaking at the 3DHEALS 2020 virtual conference, Sam Onukuri from Johnson & Johnson discusses the emergence of 3D Printing in healthcare coinciding with new expectations from customers.
There are plenty of machine shops content to remain a certain size while shying away from change and expansion. However, other shops embrace that challenge with relish.
John Rice, president, CEO and director of Sigma Labs Inc., discusses aerospace's adoption of 3D printing in an interview with SME Media.
Stratasys Ltd. said it agreed to acquire 3D printing start-up Origin Inc. in a transaction for total consideration of up to $100 million, including cash and stock.